1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mechanisms of resistance to CDK4/6 inhibitors and new therapeutic approaches
    Meeting Abstract

    Chandarlapaty, S.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Whole-exome and RNA-sequencing analyses of acinic cell carcinomas of the breast
    Meeting Abstract

    Beca, F.; Lee, S. S. K.; Pareja, F.; Da Cruz Paula, A.; Selenica, P.; Ferrando, L.; Wen, H. Y.; Zhang, H.; Guerini-Rocco, E.; Rakha, E. A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Phase 1/2 dose-escalation and expansion study investigating SAR439859, a potent, oral, selective estrogen receptor degrader, +/- palbociclib in metastatic breast cancer
    Meeting Abstract

    Campone, M.; Bardia, A.; Ulaner, G. A.; Chandarlapaty, S.; Gosselin, A.; Doroumian, S.; Celanovic, M.; Linden, H. M.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Dose-escalation study of SAR439859, an oral selective estrogen receptor degrader, in postmenopausal women with estrogen receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer
    Meeting Abstract

    Campone, M.; Bardia, A.; Ulaner, G. A.; Chandarlapaty, S.; Gosselin, A.; Doroumian, S.; Ming, J.; Celanovic, M.; Linden, H. M.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Extra help for neuron grafts
    Editorial

    Studer, L.; Tabar, V.
    Nature (2020)

    Fulltext@MSK | Save
  • Long-term outcomes and responses to retreatment in patients with melanoma treated with PD-1 blockade
    Journal Article

    Warner, A. B.; Palmer, J. S.; Shoushtari, A. N.; Goldman, D. A.; Panageas, K. S.; Hayes, S. A.; Bajwa, R.; Momtaz, P.; Callahan, M. K.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Cascading after peridiagnostic cancer genetic testing: An alternative to population-based screening
    Journal Article

    Offit, K.; Tkachuk, K. A.; Stadler, Z. K.; Walsh, M. F.; Diaz-Zabala, H.; Levin, J. D.; Steinsnyder, Z.; Ravichandran, V.; Sharaf, R. N.; Frey, M. K.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prospective feasibility trial of a novel strategy of facilitated cascade genetic testing using telephone counseling
    Journal Article

    Frey, M. K.; Kahn, R. M.; Chapman-Davis, E.; Tubito, F.; Pires, M.; Christos, P.; Anderson, S.; Mukherjee, S.; Jordan, B.; Blank, S. V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: A systematic review and meta-analysis
    Review

    Woo, S.; Panebianco, V.; Narumi, Y.; Del Giudice, F.; Muglia, V. F.; Takeuchi, M.; Ghafoor, S.; Bochner, B. H.; Goh, A. C.; Hricak, H.; more...
    European Urology Oncology (2020)

    Fulltext@MSK | Save
  • Tumor analyses reveal squamous transformation and off-target alterations as early resistance mechanisms to first-line osimertinib in EGFR-mutant lung cancer
    Journal Article

    Schoenfeld, A. J.; Chan, J. M.; Kubota, D.; Sato, H.; Rizvi, H.; Daneshbod, Y.; Chang, J. C.; Paik, P. K.; Offin, M.; Arcila, M. E.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save